Maximilian Seles
Graz, Austria
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Towards Defining Follow-up Strategies for Patients with Primary Intermediate-risk Non-muscle-invasive Bladder Cancer.
Journal: European urology oncology
Published: December 02, 2024
Does Laterality Affect the Risk of Intraoperative Complications in Adrenalectomy?
Journal: Journal of surgical oncology
Published: August 28, 2024
Intermediate- and Long-term Results After Adjustable Transobturator Male System Implantation.
Journal: Urology
Published: August 10, 2024
Second TURB, restaging TURB or repeat TURB in primary T1 non-muscle invasive bladder cancer: impact on prognosis?
Journal: International urology and nephrology
Published: October 12, 2023
Human Tularemia Epididymo-Orchitis Caused by Francisella tularensis Subspecies holartica, Austria.
Journal: Emerging infectious diseases
Published: September 22, 2023
Differences in overall survival of penile cancer patients versus population-based controls.
Journal: International journal of urology : official journal of the Japanese Urological Association
Published: June 19, 2023
Erratum to "European Association of Urology (EAU) Prognostic Factor Risk Groups for Non-muscle-invasive Bladder Cancer (NMIBC) Incorporating the WHO 2004/2016 and WHO 1973 Classification Systems for Grade: An Update from the EAU NMIBC Guidelines Panel" [Eur. Urol. 79(4) (2021) 480-488].
Journal: European urology
Published: February 25, 2023
Preoperative fibrinogen/CRP score predicts survival in upper urothelial tract carcinoma patients undergoing radical curative surgery.
Journal: World journal of urology
Published: January 11, 2023
Prognosis of Primary Papillary Ta Grade 3 Bladder Cancer in the Non-muscle-invasive Spectrum.
Journal: European urology oncology
Published: August 23, 2022
Combining targeted and systematic prostate biopsy improves prostate cancer detection and correlation with the whole mount histopathology in biopsy naïve and previous negative biopsy patients.
Journal: Frontiers in surgery
Published: August 06, 2022
Improved overall survival of metastatic renal cell carcinoma patients in the era of modern tyrosine kinase inhibitors and immune checkpoint inhibitors: results from a real-life, population-based Austrian study comprising three decades of follow-up.
Journal: Therapeutic advances in medical oncology
Published: March 11, 2022
T1G1 Bladder Cancer: Prognosis for this Rare Pathological Diagnosis Within the Non-muscle-invasive Bladder Cancer Spectrum.
Journal: European urology focus
Published: March 04, 2022
Last Updated: 09/26/2026